Correlating Echinocandin MIC and Kinetic Inhibition of fks1 Mutant Glucan Synthases for Candida albicans : Implications for Interpretive Breakpoints

Cited by (258)

Items 101–200 of 258

1. Clinically significant micafungin resistance in Candida albicans involves modification of a glucan synthase catalytic subunit GSC1 (FKS1) allele followed by loss of heterozygosity
   Kyoko Niimi, Brian C. Monk, Asuka Hirai, Kazuaki Hatakenaka, Takashi Umeyama, Erwin Lamping, Katsuyuki Maki, Koichi Tanabe, Tomohiko Kamimura, Fumiaki Ikeda et al. · 2010 · Journal of Antimicrobial Chemotherapy
2. Stepwise development of a homozygous S80P substitution in Fks1p, conferring echinocandin resistance in Candida tropicalis.
   Jensen, Rasmus Hare, Johansen, Helle Krogh, Arendrup, Maiken Cavling · 2013 · Antimicrobial Agents and Chemotherapy
3. Old and new pathogenicNakaseomycesspecies: epidemiology, biology, identification, pathogenicity and antifungal resistance
   A. Angoulvant, J. Guitard, C. Hennequin · 2015 · FEMS Yeast Research
4. Pharmacokinetics and Pharmacodynamics of Antibacterials, Antifungals, and Antivirals Used Most Frequently in Neonates and Infants
   Jessica K. Roberts, Chris R. Stockmann, Jonathan E. Constance, Justin Stiers, Michael G. Spigarelli, Robert M. Ward, Catherine M.T. Sherwin · 2014 · Clinical Pharmacokinetics
5. Overcoming the Resistance Hurdle: Pharmacokinetic-Pharmacodynamic Target Attainment Analyses for Rezafungin (CD101) against Candida albicans and Candida glabrata
   Justin C. Bader, Elizabeth A. Lakota, Shawn Flanagan, Voon S. Ong, Taylor Sandison, Christopher M. Rubino, Sujata M. Bhavnani, Paul G. Ambrose · 2018 · Antimicrobial Agents and Chemotherapy
6. Echinocandin Resistance in Candida Species Isolates from Liver Transplant Recipients
   Gwénolé Prigent, Nawel Aït‐Ammar, Éric Levesque, Arnaud Fekkar, Jean‐Marc Costa, Sarra El Anbassi, F. Foulet, Christophe Duvoux, Jean‐Claude Merle, Éric Dannaoui et al. · 2016 · Antimicrobial Agents and Chemotherapy
7. Evaluation of Caspofungin Susceptibility Testing by the New Vitek 2 AST-YS06 Yeast Card Using a Unique Collection of FKS Wild-Type and Hot Spot Mutant Isolates, Including the Five Most Common Candida Species
   Astvad, Karen M., Perlin, David S., Johansen, Helle K., Jensen, Rasmus H., Arendrup, Maiken C. · 2013 · Antimicrobial Agents and Chemotherapy
8. Emerging Mechanisms of Drug Resistance in Candida albicans
   Rajendra Prasad, Remya Nair, Atanu Banerjee · 2019 · Progress in molecular and subcellular biology
9. Echinocandin Resistance in Candida Species: a Review of Recent Developments
   Nathan P. Wiederhold · 2016 · Current Infectious Disease Reports
10. Efg1 Controls Caspofungin-Induced Cell Aggregation of Candida albicans through the Adhesin Als1
    Christa Gregori, Walter Glaser, Ingrid E. Frohner, Cristina Reinoso-Martín, Steffen Rupp, Christoph Schüller, Karl Kuchler · 2011 · Eukaryotic Cell
11. A Linear 19-Mer Plant Defensin-Derived Peptide Acts Synergistically with Caspofungin against Candida albicans Biofilms
    Tanne L. Cools, Caroline Struyfs, Jan Wouter Drijfhout, Soňa Kucharíková, Celia Lobo Romero, Patrick Van Dijck, Marcelo Henrique Soller Ramada, Carlos Bloch, Bruno P.A. Cammue, Karin Thevissen · 2017 · Frontiers in Microbiology
12. Resistance to antifungal therapies
    Rajendra Prasad, Atanu Banerjee, Abdul Haseeb Shah · 2017 · Essays in Biochemistry
13. Modulation of Alternaria infectoria Cell Wall Chitin and Glucan Synthesis by Cell Wall Synthase Inhibitors
    Chantal Fernandes, Jorge Anjos, Louise A. Walker, Branca M. A. Silva, Luísa Cortes, Marta Mota, Carol A. Munro, Neil A. R. Gow, Teresa Gonçalves · 2014 · Antimicrobial Agents and Chemotherapy
14. Interactions of Yeasts, Moulds, and Antifungal Agents
    Gerri S. Hall · 2011 · Humana Press eBooks
15. EUCAST and CLSI: Working Together Towards a Harmonized Method for Antifungal Susceptibility Testing
    Ana Espinel‐Ingroff, Manuel Cuenca‐Estrella, Emilia Cantón · 2013 · Current Fungal Infection Reports
16. Echinocandin resistance due to simultaneous FKS mutation and increased cell wall chitin in a Candida albicans bloodstream isolate following brief exposure to caspofungin
    Toufeeq Imtiaz, Kathy K. Lee, Carol A. Munro, Donna M. MacCallum, Gillian S. Shankland, Elizabeth M. Johnson, Mark S. MACGREGOR, Abhijit M. Bal · 2012 · Journal of Medical Microbiology
17. The fission yeast cell wall stress sensor‐like proteins Mtl2 and Wsc1 act by turning on the GTP ase Rho1p but act independently of the cell wall integrity pathway
    Sandra Cruz, Sofía Muñoz, Elvira Manjón, Patrícia Salomão Garcia, Yolanda Sanchez · 2013 · MicrobiologyOpen
18. Improved Detection of Candida sp. fks Hot Spot Mutants by Using the Method of the CLSI M27-A3 Document with the Addition of Bovine Serum Albumin
    Guillermo García‐Effrón, Steven Park, David S. Perlin · 2011 · Antimicrobial Agents and Chemotherapy
19. DifferentialAspergillus lentulusEchinocandin Susceptibilities Are Fksp Independent
    Janet F. Staab, Jennifer Nielsen Kahn, Kieren A. Marr · 2010 · Antimicrobial Agents and Chemotherapy
20. Evaluation of a Novel FKS1 R1354H Mutation Associated with Caspofungin Resistance in Candida auris Using the CRISPR-Cas9 System
    Maiko Kiyohara, Taiga Miyazaki, Michiyo Okamoto, Tatsuro Hirayama, Koichi Makimura, Hiroji Chibana, Nana Nakada, Yuya Ito, Makoto Sumiyoshi, Nobuyuki Ashizawa et al. · 2023 · Journal of Fungi
21. Biofilm production and antibiofilm activity of echinocandins and liposomal amphotericin B in echinocandin-resistant yeast species
    Marcos-Zambrano, Laura Judith, Gómez-Perosanz, Marta, Escribano, Pilar, Zaragoza, Oscar, Bouza, Emilio, Guinea, Jesús · 2016 · Antimicrobial Agents and Chemotherapy
22. Role of FKS Gene in the Susceptibility of Pathogenic Fungi to Echinocandins
    Yasuhiro Hori, Kazutoshi Shibuya · 2018 · Medical Mycology Journal
23. Genome sequence of the opportunistic human pathogen Magnusiomyces capitatus
    Broňa Brejová, Hana Lichancová, Filip Brázdovič, Eva Hegedűsová, Michaela Jakúbková, Viktória Hodorová, Vladimíra Džugasová, Andrej Baláž, Lucia Zeiselová, Andrea Cillingová et al. · 2018 · Current Genetics
24. Molecular Markers of Antifungal Resistance: Potential Uses in Routine Practice and Future Perspectives
    Guillermo García‐Effrón · 2021 · Journal of Fungi
25. Chemical reactivity and antimicrobial activity of N -substituted maleimides
    Natalia Salewska, Joanna Boros-Majewska, Izabela Łącka, Katarzyna Chylińska, Michał Sabisz, Sławomir Milewski, Maria J. Milewska · 2011 · Journal of Enzyme Inhibition and Medicinal Chemistry
26. Echinocandin Failure Case Due to a Previously Unreported FKS1 Mutation in Candida krusei
    Rasmus Krøger Hare, Ulrik Stenz Justesen, Annika Rewes, David S. Perlin, Maiken Cavling Arendrup · 2014 · Antimicrobial Agents and Chemotherapy
27. Evaluation of CLSI M44-A2 Disk Diffusion and Associated Breakpoint Testing of Caspofungin and Micafungin Using a Well-Characterized Panel of Wild-Type and fks Hot Spot Mutant Candida Isolates
    Maiken Cavling Arendrup, Steven Park, Steven D. Brown, Michael A. Pfaller, David S. Perlin · 2011 · Antimicrobial Agents and Chemotherapy
28. Echinocandins: Addressing outstanding questions surrounding treatment of invasive fungal infections
    Holt, Shannon L., Drew, Richard H. · 2011 · American Journal of Health-System Pharmacy
29. Reshaping Echinocandin Antifungal Drugs To Circumvent Glucan Synthase Point‐Mutation‐Mediated Resistance
    Moriah Jospe‐Kaufman, Efrat Ben‐Zeev, Austin Mottola, Anna Dukhovny, Judith G. Berman, Shmuel Carmeli, Micha Fridman · 2023 · Angewandte Chemie International Edition
30. Cell Wall-Modifying Antifungal Drugs
    David S. Perlin · 2019 · Current topics in microbiology and immunology
31. Review on fungal enzyme inhibitors – potential drug targets to manage human fungal infections
    Jayapradha Ramakrishnan, Sudarshan Singh Rathore, Thiagarajan Raman · 2016 · RSC Advances
32. The Microevolution of Antifungal Drug Resistance in Pathogenic Fungi
    Kylie J. Boyce · 2023 · Microorganisms
33. Comparative in vivo dose-dependent activity of caspofungin and anidulafungin against echinocandin-susceptible and -resistant Aspergillus fumigatus
    Lewis, R. E., Liao, G., Hou, J., Prince, R. A., Kontoyiannis, D. P. · 2011 · Journal of Antimicrobial Chemotherapy
34. Development of echinocandin‐resistant C andida albicans candidemia following brief prophylactic exposure to micafungin therapy
    Michael A. Ruggero, Jeffrey E. Topal · 2014 · Transplant Infectious Disease
35. Antifungal Drugs: Mechanism of Action and Resistance
    Muhammad Zeeshan Ahmed, Tazeen Rao, Ali Saeed, Zeeshan Mutahir, Shahzeb Hameed, Samrana Inayat, Haseeba Shahzad, Najeeb Ullah, Muhammad Abaid-Ullah, Muhammad Ibrahim et al. · 2021 · Springer eBooks
36. Susceptibility of Candida species and various moulds to antimycotic drugs: use of epidemiological cutoff values according to EUCAST and CLSI in an 8-year survey
    Günter Rambach, Heidemarie Oberhauser, Cornelia Speth, Cornelia Lass‐Flörl · 2011 · Medical Mycology
37. Benzylic Dehydroxylation of Echinocandin Antifungal Drugs Restores Efficacy against Resistance Conferred by Mutated Glucan Synthase
    Dana Logviniuk, Qais Z. Jaber, Roman Dobrovetsky, Noga Kozer, Ewa Księżopolska, Toni Gabaldón, Shmuel Carmeli, Micha Fridman · 2022 · Journal of the American Chemical Society
38. Fungal echinocandin resistance
    Carol A. Munro · 2010 · F1000 Biology Reports
39. Echinocandins Localized to the Target-Harboring Cell Surface Are Not Degraded but Those Entering the Vacuole Are
    Qais Z. Jaber, Dana Logviniuk, Adi Yona, Micha Fridman · 2022 · ACS Chemical Biology
40. Comparison of Anidulafungin MICs Determined by the Clinical and Laboratory Standards Institute Broth Microdilution Method (M27-A3 Document) and Etest for Candida Species Isolates
    Ana Espinel‐Ingroff, Rafael Cantón, Javier Pemán, Estrella Martín‐Mazuelos · 2009 · Antimicrobial Agents and Chemotherapy
41. Etest and Sensititre YeastOne Susceptibility Testing of Echinocandins against Candida Species from a Single Center in Austria
    Maria Aigner, Thomas Erbeznik, Martin Gschwentner, Cornelia Lass‐Flörl · 2017 · Antimicrobial Agents and Chemotherapy
42. Comparison of Dimethyl Sulfoxide and Water as Solvents for Echinocandin Susceptibility Testing by the EUCAST Methodology
    Ana Alastruey‐Izquierdo, Alicia Gómez‐López, Maiken Cavling Arendrup, Cornelia Lass‐Flörl, William W. Hope, David S. Perlin, Juan L. Rodrı́guez-Tudela, Manuel Cuenca‐Estrella · 2012 · Journal of Clinical Microbiology
43. Genotypic, proteomic, and phenotypic approaches to decipher the response to caspofungin and calcineurin inhibitors in clinical isolates of echinocandin-resistant Candida glabrata
    Ceballos-Garzon, Andres, Monteoliva, Lucia, Gil, Concha, Alvarez-Moreno, Carlos, Vega-Vela, Nelson E, Engelthaler, David M, Bowers, Jolene, Le Pape, Patrice, Parra-Giraldo, Claudia M · 2022 · Journal of Antimicrobial Chemotherapy
44. Echinocandin-Resistant Candida: Molecular Methods and Phenotypes
    David S. Perlin · 2011 · Current Fungal Infection Reports
45. Antifungal resistance, combinations and pipeline: oh my!
    Kayla R. Stover, Brandon K. Hawkins, Jacob M. Keck, Katie E. Barber, David A. Cretella · 2023 · Drugs in Context
46. Minimal Inhibitory Concentration (MIC)-Phenomena in Candida albicans and Their Impact on the Diagnosis of Antifungal Resistance
    Ulrike Binder, Maria Aigner, Brigitte Risslegger, Caroline Hörtnagl, Cornelia Lass‐Flörl, Michaela Lackner · 2019 · Journal of Fungi
47. Gemini quaternary ammonium compound PMT12-BF4 inhibits Candida albicans via regulating iron homeostasis
    Li-Hang Hsu, Dobrawa Kwaśniewska, Shih-Cheng Wang, Tang‐Long Shen, Daria Wieczorek, Ying‐Lien Chen · 2020 · Scientific Reports
48. Efg1 and Cas5 Orchestrate Cell Wall Damage Response to Caspofungin in Candida albicans
    Kang Xiong, Chang Su, Qiangqiang Sun, Yang Lü · 2020 · Antimicrobial Agents and Chemotherapy
49. Antimycotic Drugs and their Mechanisms of Resistance to Candida Species
    Sweety Dahiya, Namita Sharma, Aruna Punia, Pooja Choudhary, Prity Gulia, Virinder Singh Parmar, Anil Kumar Chhillar · 2021 · Current Drug Targets
50. Quick Detection of FKS1 Mutations Responsible for Clinical Echinocandin Resistance in Candida albicans
    Catiana Dudiuk, Soledad Pinto Gamarra, Cristina Jiménez‐Ortigosa, Florencia Leonardelli, Daiana Macedo, David S. Perlin, Guillermo García‐Effrón · 2015 · Journal of Clinical Microbiology
51. Prevalence and Antifungal Susceptibility of the Emerging Fungal Species, Candida nivariensis , Isolated in a Teaching Hospital in Poland
    Magdalena Sikora, Robert Kuthan, Katarzyna Piskorska, Marlena Gołaś-Prądzyńska, Dariusz Domański, EWA M. AUGUSTYNOWICZ-KOPEĆ, Ewa Swoboda‐Kopeć · 2019 · Polish Journal of Microbiology
52. Candida albicans Modulates Murine and Human Beta Defensin-1 during Vaginitis
    María Soledad Miró, Juan Pablo Caeiro, Emilse Rodríguez, Lara Vargas, Cecilia Vigezzi, Paula Alejandra Icely, Graciela del Valle Castillo, Ana Isabel Azcurra, Claudio Daniel Abiega, Fernando Oscar Riera et al. · 2021 · Journal of Fungi
53. Anidulafungin: when and how? The clinician’s view
    Jomy M. George, Annette C. Reboli · 2011 · Mycoses
54. Reconstitution of high-level micafungin resistance detected in a clinical isolate of Candida glabrata identifies functional homozygosity in glucan synthase gene expression
    Kyoko Niimi, Matthew A. Woods, Katsuyuki Maki, Hironobu Nakayama, Kazuaki Hatakenaka, Hiroji Chibana, Fumiaki Ikeda, Keigo Ueno, Masakazu Niimi, Richard David Cannon et al. · 2012 · Journal of Antimicrobial Chemotherapy
55. Target Enzyme Mutations Confer Differential Echinocandin Susceptibilities in Candida kefyr
    Janet F. Staab, Dionysios Neofytos, Peter Rhee, Cristina Jiménez‐Ortigosa, Sean X. Zhang, David S. Perlin, Kieren A. Marr · 2014 · Antimicrobial Agents and Chemotherapy
56. The challenges of the genome-based identification of antifungal resistance in the clinical routine
    Ana Alastruey‐Izquierdo, Antonio J. Martín-Galiano · 2023 · Frontiers in Microbiology
57. Comparison between the EUCAST Procedure and the Etest for Determination of the Susceptibility of Candida Species Isolates to Micafungin
    Laura Judith Marcos-Zambrano, Pilar Escribano, Cristina Rueda, Óscar Zaragoza, Emilio Bouza, Jesús Guinea · 2013 · Antimicrobial Agents and Chemotherapy
58. Comparison of the Etest and a rapid flow cytometry-based method with the reference CLSI broth microdilution protocol M27-A3 for the echinocandin susceptibility testing of Candida spp.
    Luís A. Vale-Silva, P. Pinto, Vítor Lopes, Helena Ramos, Eugénia Pinto · 2011 · European Journal of Clinical Microbiology & Infectious Diseases
59. A Review on Molecular Mechanisms of Antifungal Resistance in Candida glabrata : Update and Recent Advances
    Ensieh Lotfali, Azam Fattahi, Shirin Sayyahfar, Reza Ghasemi, Mohammad Mahdi Rabiei, Mobina Fathi, Kimia Ghazi Vakili, Niloofar Deravi, Amirali Soheili, Hossein Toreyhi et al. · 2021 · Microbial Drug Resistance
60. Tetraploidy accelerates adaptation under drug selection in a fungal pathogen
    Ognenka Avramovska, Amanda C Smith, Emily Rego, Meleah A. Hickman · 2022 · Frontiers in Fungal Biology
61. Biomarkers of caspofungin resistance in Candida albicans isolates: A proteomic approach
    Giuseppe Buda De Cesare, Ahmed Ibrahem Hafez, David Stead, Carlos Lloréns, Carol A. Munro · 2022 · Virulence
62. Anidulafungin, a New Echinocandin
    Giulia Morace, Elisa Borghi, Roberta Iatta, Maria Teresa Montagna · 2009 · Drugs
63. Echinocandin Antifungal Drug Resistance in Candida Species: A Cause for Concern?
    Maurizio Sanguinetti, Patrizia Posteraro, Brunella Posteraro · 2010 · Current Infectious Disease Reports
64. Genome-Wide Response to Drugs and Stress in the Pathogenic Yeast Candida glabrata
    Pedro Pais, Mónica Galocha, Miguel Cacho Teixeira · 2019 · Progress in molecular and subcellular biology
65. Antifungal Resistance Testing and Implications for Management
    Hamid Badali, Nathan P. Wiederhold · 2019 · Current Fungal Infection Reports
66. Epidemiological and Microbiological aspects of Candidozyma auris (Candida auris) in Latin America: A literature review
    Mariana Lanna, Josefina Elizabeth Lovatto, João Nóbrega de Almeida, Eduardo Alexandrino Medeiros, Arnaldo Lopes Colombo, Guillermo García‐Effrón · 2025 · Journal de Mycologie Médicale
67. β(1,3)-glucan synthase complex fromAlternaria infectoria, a rare dematiaceous human pathogen
    Jorge Anjos, Chantal Fernandes, Branca M. A. Silva, Célia Quintas, Alexandra Abrunheiro, Neil A. R. Gow, Teresa Gonçalves · 2012 · Medical Mycology
68. Inhibiting Fungal Echinocandin Resistance by Small-Molecule Disruption of Geranylgeranyltransferase Type I Activity
    Qiangqiang Sun, Kang Xiong, Yuncong Yuan, Jing Yu, Lianjuan Yang, Chao Shen, Chang Su, Yang Lü · 2019 · Antimicrobial Agents and Chemotherapy
69. First report of Candida bracarensis in Mexico: hydrolytic enzymes and antifungal susceptibility pattern
    Rogelio de J. Treviño‐Rangel, José F. Espinosa-Pérez, Hiram Villanueva‐Lozano, Alexandra M. Montoya, Ángel Andrade, Alexandro Bonifáz, Gloria María González · 2018 · Folia Microbiologica
70. Development of Echinocandin Resistance in Candida haemulonii: An Emergent, Widespread, and Opportunistic Fungal Pathogen
    Laura Nunes Silva, Lívia S. Ramos, Simone S. C. Oliveira, Lucas B. Magalhães, Jefferson Bomfim Silva Cypriano, Fernanda de Ávila Abreu, Alexandre José Macêdo, Marta H. Branquinha, André Luis Souza dos Santos · 2023 · Journal of Fungi
71. Mutational landscape and molecular bases of echinocandin resistance in Saccharomyces cerevisiae
    Romain Durand, Alexandre G. Torbey, Mathieu Giguere, Alicia Pageau, Alexandre K. Dubé, Patrick Lagüe, Christian R. Landry · 2026 · Genetics
72. In vitro assessment of the antifungal and paradoxical activity of different echinocandins against Candida tropicalis biofilms
    Tsun Sheng N. Ku, Stella M. Bernardo, Samuel A. Lee · 2011 · Journal of Medical Microbiology
73. Candida Biofilm Tolerance: Comparison of Planktonic and Biofilm Resistance Mechanisms
    Eddie G. Dominguez, David R. Andes · 2017 · Springer eBooks
74. Antifungal Activity of Oleylphosphocholine on In Vitro and In Vivo Candida albicans Biofilms
    Michelle Holtappels, Erwin Swinnen, Lies De Groef, Jurgen Wuyts, Lieve Moons, Katrien Lagrou, Patrick Van Dijck, Soňa Kucharíková · 2017 · Antimicrobial Agents and Chemotherapy
75. Sequencing of FKS Hot Spot 1 from Saprochaete capitata To Search for a Relationship to Reduced Echinocandin Susceptibility
    Inés Arrieta-Aguirre, Pilar Menéndez-Manjón, María Soledad Cuétara, Íñigo Fernandez-de-Larrinoa, Juan Carlos García‐Ruiz, Maria Dolores Moragues · 2017 · Antimicrobial Agents and Chemotherapy
76. Highly Specific and Rapid Multiplex Identification of Candida Species Using Digital Microfluidics Integrated with a Semi-Nested Genoarray
    Zeyin Mao, Anni Deng, Xiangyu Jin, Tianqi Zhou, Shuailong Zhang, Meng Li, Wenqi Lv, Leyang Huang, Hao Zhong, Shihong Wang et al. · 2024 · Analytical Chemistry
77. Antifúngicos en el tratamiento de las infecciones sistémicas: importancia del mecanismo de acción, espectro de actividad y resistencias
    Manuel Cuenca‐Estrella · 2010 · Revista española de quimioterapia. Suplemento
78. Pharmacokinetics, antifungal activity and clinical efficacy of anidulafungin in the treatment of fungal infections
    Effie L. Kuti, Joseph L. Kuti · 2010 · Expert Opinion on Drug Metabolism & Toxicology
79. Species-Specific Sensitivity and Levels of Beta-D-Glucan for the Diagnosis of Candidemia—A Systematic Review and Meta-Analysis
    Nadir Ullah, Marco Muccio, Laura Magnasco, Chiara Sepulcri, Daniele Roberto Giacobbe, Antonio Vena, Matteo Bassetti, Małgorzata Mikulska · 2025 · Journal of Fungi
80. Challenging SNP impact on caspofungin resistance by full-lengthFKS1allele replacement inCandida lusitaniae
    Isabelle Accoceberry, Célia Couzigou, Valérie Fitton‐Ouhabi, Nicolas Biteau, Thierry Noël · 2018 · Journal of Antimicrobial Chemotherapy
81. In vitro activity of echinocandins against non-Candida albicans: Is echinocandin antifungal activity the same?
    Ana Espinel‐Ingroff, Emilia Cantón · 2011 · Enfermedades Infecciosas y Microbiología Clínica
82. Caspofungin: when and how? The microbiologist’s view
    Astrid Mayr, Maria Aigner, Cornelia Lass‐Flörl · 2011 · Mycoses
83. Resistance to Echinocandins in Candida Can Be Detected by Performing the Etest Directly on Blood Culture Samples
    María Ángeles Bordallo-Cardona, Laura Judith Marcos-Zambrano, Carlos Sánchez‐Carrillo, Emilio Bouza, Patricia Muñóz, Pilar Escribano, Jesús Guinea · 2018 · Antimicrobial Agents and Chemotherapy
84. New antifungal agents for the treatment of candidaemia
    Patricia Muñóz, Jesús Guinea, Loreto Rojas, Emilio Bouza · 2010 · International Journal of Antimicrobial Agents
85. Development of Carbazole Derivatives Compounds against Candida albicans: Candidates to Prevent Hyphal Formation via the Ras1-MAPK Pathway
    Young-Kwang Park, Jisoo Shin, Hee‐Yoon Lee, Hag-Dong Kim, Joon Kim · 2021 · Journal of Fungi
86. Actividad antifúngica in vitro de la micafungina
    Guillermo Quindós, Elena Eraso, Alfonso Javier Carrillo‐Muñoz, Emilia Cantón, Javier Pemán · 2009 · Revista Iberoamericana de Micología
87. Phytolacca tetramera berries extracts and its main constituents as potentiators of antifungal drugs against Candida spp.
    Estefanía Butassi, Alan Roy Blanc, Laura Andrea Svetaz · 2024 · Phytomedicine
88. Utility of Antifungal Susceptibility Testing and Clinical Correlations
    Daniel J. Diekema, Michael A. Pfaller · 2011 · Humana Press eBooks
89. Comparison of micafungin MICs as determined by the Clinical and Laboratory Standards Institute broth microdilution method (M27-A3 document) and Etest for Candida spp. isolates
    Ana Espinel‐Ingroff, Emilia Cantón, Teresa Peláez, Javier Pemán · 2011 · Diagnostic Microbiology and Infectious Disease
90. Actualización en terapia antifúngica: nuevos fármacos e indicaciones
    Jesús Fortün · 2011 · Enfermedades Infecciosas y Microbiología Clínica
91. New echinocandin susceptibility patterns for nosocomial Candida albicans in Bogotá, Colombia, in ten tertiary care centres: an observational study
    Giovanni Rodríguez-Leguizamón, Alessandro Fiori, Katrien Lagrou, María Antonia Gaona, Milcíades Ibáñez‐Pinilla, Manuel Alfonso Patarroyo, Patrick Van Dijck, Arley Gómez-López · 2015 · BMC Infectious Diseases
92. Echinocandin resistance in human pathogenic fungi
    Carol A. Munro · 2012 · Expert Review of Anti-infective Therapy
93. Structural basis of fungal β-1,3-glucan synthase inhibition by caspofungin
    Zhenning Ren, Abhishek Chhetri, Chang Liu, ShuYu Offner, Kedar Sharma, Mario Juan Borgnia, Wonpil Im, Kenichi Yokoyama, Seok‐Yong Lee · 2026 · Nature
94. Reshaping Echinocandin Antifungal Drugs To Circumvent Glucan Synthase Point‐Mutation‐Mediated Resistance
    Moriah Jospe‐Kaufman, Efrat Ben‐Zeev, Austin Mottola, Anna Dukhovny, Judith G. Berman, Shmuel Carmeli, Micha Fridman · 2023 · Angewandte Chemie
95. Tn-seq screens in Candida glabrata treated with echinocandins and ibrexafungerp reveal pathways of antifungal resistance and cross-resistance
    Nickels, Timothy J., Cunningham, Kyle W. · 2025 · mSphere
96. Mechanisms of Resistance to Antifungal Agents
    David S. Perlin · 2015 · ASM Press eBooks
97. Anidulafungin and its role in candida infections
    Diane M. Cappelletty · 2009 · Infection and Drug Resistance
98. Pharmacotherapy of Candida Infections with Echinocandins
    Ana Victoria Espinel-Ingroff, Emilia Canton, Estrella Martín‐Mazuelos, Javier Pemán · 2009 · Clinical Medicine Therapeutics
99. Preparation and evaluation of 99mTc-anidulafungin: a potential radiotracer for fungal infection
    O. A. El‐Kawy, Magda Sayed, A. S. Abdel-Razek · 2020 · Journal of Radioanalytical and Nuclear Chemistry
100. Prévalence de Candida parapsilosis, C. orthopsilosis et de C. metapsilosis au sein des candidémies au CHU de Nantes et profil de sensibilité aux échinocandines par la méthode E-test® : étude rétrospective de cinq ans (2004–2009)
     G. Thierry, Florent Morio, Patrice Le Pape, Françoise Gay‐Andrieu, O. Barre, Michel Miegeville · 2010 · Pathologie Biologie